Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Sep 15 · below the Ichimoku cloud · RSI 37 · MACD above its signal
None of the 29 investors followed here reported a position in RELV in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a RELV trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for RELV.
No analyst coverage for this instrument.
Reliv' International, Inc. develops, manufactures, and markets proprietary nutritional supplements. The company offers joint health, protein, gluten free, targeted solutions, blood sugar support, cellular health, cognitive functions and focus, cholesterol support, kid's nutrition, digestive health, discomfort, energy, aging, heart health, hemp, and immune support products. It also provides multivitamins, omega 3s, probiotics, weight management, dairy and soy free, vegetarian, and vegan products. The company offers its products under the fibrestore, Reliv Classic, Innergize!, and LunaRich C brands. It operates in the United States, Canada, Mexico, the United Kingdom, Ireland, Germany, Australia, New Zealand, the Philippines, Malaysia, Singapore, Austria, the Netherlands, and France. The company was founded in 1988 and is headquartered in Chesterfield, Missouri.
No recent headlines.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0 | 0.0 | -8.0 | -3.4 | 12.5 | -15.6 | -3.7 | 0.0 | -9.8 | 0.0 | −26.7% | ||
| 2025 | -12.5 | -14.9 | 1.4 | 1.4 | 0.0 | -23.0 | 12.1 | -2.7 | 0.0 | -3.2 | 9.0 | -15.4 | −42.6% |
| 2024 | 6.2 | -8.4 | 2.8 | 4.1 | 55.8 | -39.3 | -1.1 | 1.4 | -8.2 | -1.2 | -1.8 | 20.6 | +5.9% |
| 2023 | 0.0 | 24.5 | 0.0 | -21.0 | 0.0 | 11.0 | 2.5 | -8.9 | 1.3 | -1.3 | 14.8 | -14.7 | −0.3% |
| 2022 | 11.8 | -15.8 | -2.5 | 6.9 | 0.0 | -4.8 | 25.2 | 0.0 | -9.5 | -11.1 | -3.8 | -3.6 | −12.7% |
| 2021 | 14.3 | 8.7 | -19.5 | 4.3 | 4.7 | -4.2 | 23.0 | -11.1 | -6.3 | 7.2 | 2.0 | 3.7 | +21.4% |
| 2020 | 1.4 | -12.4 | -2.0 | -16.9 | 32.1 | -2.7 | 2.5 | -13.3 | 6.9 | 5.0 | 3.9 | -6.2 | −9.6% |
| 2019 | 1.3 | -3.8 | 4.1 | 2.3 | 10.9 | -13.5 | -3.3 | 1.2 | 8.1 | -1.9 | -8.9 | -3.0 | −8.6% |
| 2018 | 9.2 | 3.6 | -11.9 | -4.0 | 2.8 | 2.8 | 0.0 | 6.4 | -1.8 | -7.5 | 4.9 | -13.6 | −11.2% |
| 2017 | -7.5 | 35.9 | -8.7 | 19.7 | 24.2 | 11.0 | 16.9 | -25.0 | -13.1 | -14.1 | -16.3 | -0.8 | +2.8% |
| 2016 | -5.6 | 56.3 | -20.4 | -6.8 | 514.5 | -2.6 | 12.3 | +636.5% |